Literature DB >> 11123421

The characteristics of Epstein-Barr virus (EBV)-positive diffuse large B-cell lymphoma: comparison between EBV(+) and EBV(-) cases in Japanese population.

T Kuze1, N Nakamura, Y Hashimoto, Y Sasaki, M Abe.   

Abstract

We have investigated 114 cases with diffuse large B-cell lymphoma (DLBCL) to clarify the characteristics of DLBCL with Epstein-Barr virus (EBV) infection. Thirteen cases (11.4%) showed EBV-encoded RNA 1 (EBER1) signals by RNA in situ hybridization. EBV-encoded latent membrane protein 1 (LMP1) and EBV-encoded nuclear antigen 2 (EBNA2) were expressed in 11 and 4 cases, respectively. Expression of CD30, Bcl-6 and immunoglobulin (Ig) was found in 92%, 31% and 23% with EBV(+) DLBCL, and in 15%, 79% and 82% with EBV(-) DLBCL, respectively. The sequence of rearranged Ig heavy chain (IgH) variable (V) region gene was analyzed in 5 cases with EBV(+) DLBCL and 61 cases with EBV(-) DLBCL. Somatic mutation was found in all cases except one with EBV(-) DLBCL. Average mutation frequency was 9.6% in EBV(+) DLBCL vs. 11.5% in EBV(-) DLBCL. The rates of replacement mutation vs. silent mutation (R / S values) in complementarity determining region II and framework region III were 2.7 and 1.5 in EBV(+) DLBCL, 2.6 and 1.4 in EBV(-) DLBCL. Crippling mutation generating a stop codon was found in 2 of 5 cases (40%) with EBV(+) DLBCL, but none of 61 cases (0%) with EBV(-) DLBCL. These findings suggest that EBV(+) DLBCL and EBV(-) DLBCL were both derived from germinal center (GC) or post-GC B cells, and EBV(+) DLBCL frequently have a non-functional IgH gene owing to crippling mutation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11123421      PMCID: PMC5926305          DOI: 10.1111/j.1349-7006.2000.tb00909.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  33 in total

1.  Detection of minimal disease using rearranged immunoglobulin heavy chain genes from intermediate- and high-grade malignant B cell non-Hodgkins lymphoma.

Authors:  N van Belzen; P E Hupkes; D Doekharan; M Hoogeveen-Westerveld; L C Dorssers; M B van't Veer
Journal:  Leukemia       Date:  1997-10       Impact factor: 11.528

Review 2.  Insight into the origin and clonal history of B-cell tumors as revealed by analysis of immunoglobulin variable region genes.

Authors:  F Stevenson; S Sahota; D Zhu; C Ottensmeier; C Chapman; D Oscier; T Hamblin
Journal:  Immunol Rev       Date:  1998-04       Impact factor: 12.988

3.  Analysis of VH genes in follicular and diffuse lymphoma shows ongoing somatic mutation and multiple isotype transcripts in early disease with changes during disease progression.

Authors:  C H Ottensmeier; A R Thompsett; D Zhu; B S Wilkins; J W Sweetenham; F K Stevenson
Journal:  Blood       Date:  1998-06-01       Impact factor: 22.113

4.  LAZ3, a novel zinc-finger encoding gene, is disrupted by recurring chromosome 3q27 translocations in human lymphomas.

Authors:  J P Kerckaert; C Deweindt; H Tilly; S Quief; G Lecocq; C Bastard
Journal:  Nat Genet       Date:  1993-09       Impact factor: 38.330

5.  Hodgkin's disease with a B-cell phenotype often shows a VDJ rearrangement and somatic mutations in the VH genes.

Authors:  J Tamaru; M Hummel; M Zemlin; B Kalvelage; H Stein
Journal:  Blood       Date:  1994-08-01       Impact factor: 22.113

6.  Epstein-Barr virus infection and its gene expression in gastric lymphoma of mucosa-associated lymphoid tissue.

Authors:  W S Xu; A C Chan; J M Lee; R H Liang; F C Ho; G Srivastava
Journal:  J Med Virol       Date:  1998-12       Impact factor: 2.327

7.  Analysis of Epstein-Barr viral genomes in lymphoid malignancy using Southern blotting, polymerase chain reaction and in situ hybridization.

Authors:  K Ohshima; M Kikuchi; F Eguchi; Y Masuda; Y Sumiyoshi; H Mohtai; M Takeshita; N Kimura
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1990

8.  Description of an in situ hybridization methodology for detection of Epstein-Barr virus RNA in paraffin-embedded tissues, with a survey of normal and neoplastic tissues.

Authors:  K L Chang; Y Y Chen; D Shibata; L M Weiss
Journal:  Diagn Mol Pathol       Date:  1992-12

Review 9.  A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group.

Authors:  N L Harris; E S Jaffe; H Stein; P M Banks; J K Chan; M L Cleary; G Delsol; C De Wolf-Peeters; B Falini; K C Gatter
Journal:  Blood       Date:  1994-09-01       Impact factor: 22.113

10.  Epstein-Barr virus in B-cell non-Hodgkin's lymphomas: unexpected infection patterns and different infection incidence in low- and high-grade types.

Authors:  M Hummel; I Anagnostopoulos; P Korbjuhn; H Stein
Journal:  J Pathol       Date:  1995-03       Impact factor: 7.996

View more
  18 in total

1.  Characteristics of Epstein-Barr virus associated childhood non-Hodgkin's lymphoma in the Republic of Korea.

Authors:  DongHoon Kim; YoungHyeh Ko; Yeonlim Suh; HongHoe Koo; JooRyung Huh; WonKeun Lee
Journal:  Virchows Arch       Date:  2005-07-01       Impact factor: 4.064

2.  EBNA2 interferes with the germinal center phenotype by downregulating BCL6 and TCL1 in non-Hodgkin's lymphoma cells.

Authors:  Francesco Boccellato; Eleni Anastasiadou; Paola Rosato; Bettina Kempkes; Luigi Frati; Alberto Faggioni; Pankaj Trivedi
Journal:  J Virol       Date:  2006-12-06       Impact factor: 5.103

3.  Nodular pattern of bone marrow infiltration: frequent finding in immunosuppression-related EBV-associated large B-cell lymphomas.

Authors:  Deborah W Sevilla; Erin M Weeden; Suzy Alexander; Vundavalli V Murty; Bachir Alobeid; Govind Bhagat
Journal:  Virchows Arch       Date:  2009-10-06       Impact factor: 4.064

Review 4.  Strong cross-talk between angiogenesis and EBV: do we need different treatment approaches in lymphoma cases with EBV and/or high angiogenic capacity.

Authors:  Semra Paydas
Journal:  Med Oncol       Date:  2011-09-23       Impact factor: 3.064

5.  Risk factors for intraocular involvement in patients with primary central nervous system lymphoma.

Authors:  Bum-Joo Cho; Hyeong Gon Yu
Journal:  J Neurooncol       Date:  2014-08-15       Impact factor: 4.130

Review 6.  Epstein-barr virus-positive diffuse large B-cell lymphoma of the elderly: what we know so far.

Authors:  Jorge J Castillo; Brady E Beltran; Roberto N Miranda; Semra Paydas; Eric S Winer; James N Butera
Journal:  Oncologist       Date:  2011-01-06

7.  Computed tomography findings in Epstein-Barr virus (EBV)-positive diffuse large B-cell lymphoma (DLBCL) of the elderly: comparison with EBV-negative DLBCL.

Authors:  Kouhei Tokuyama; Fumito Okada; Haruka Sato; Shunro Matsumoto; Akira Matsumoto; Ayako Haruno; Kenji Kashima; Masao Ogata; Eiichi Ohtsuka; Hiromu Mori
Journal:  Br J Radiol       Date:  2017-03-03       Impact factor: 3.039

Review 8.  Hodgkin Lymphoma: Biology and Differential Diagnostic Problem.

Authors:  Taishi Takahara; Akira Satou; Toyonori Tsuzuki; Shigeo Nakamura
Journal:  Diagnostics (Basel)       Date:  2022-06-20

9.  CD5 positivity is an independent adverse prognostic factor in elderly patients with diffuse large B cell lymphoma.

Authors:  Wen-Yu Chuang; Hung Chang; Lee-Yung Shih; Po-Nan Wang; Yu-Sun Chang; Tung-Liang Lin; Yu-Shin Hung; Chi-Ju Yeh; Shir-Hwa Ueng; Tzung-Chih Tang; Ming-Chung Kuo; Po Dunn; Jin-Hou Wu; Hsiao-Wen Kao; Che-Wei Ou; Yung-Liang Wan; Chuen Hsueh
Journal:  Virchows Arch       Date:  2015-09-14       Impact factor: 4.064

Review 10.  EBV-positive diffuse large B-cell lymphoma of the elderly.

Authors:  Chi Young Ok; Thomas G Papathomas; L Jeffrey Medeiros; Ken H Young
Journal:  Blood       Date:  2013-05-06       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.